Kyowa Kirin China Pharmaceutical Co., Ltd.

This study is testing how well and how safe the drug mogamulizumab is for Chinese adults with advanced forms of a rare skin cancer called cutaneous T-cell lymphoma. The drug is given through an IV to people whose cancer has continued to grow despite at least one prior treatment. …